A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.

About this item

Title

A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.

Content partner

The University of Auckland Library

Collection

ResearchSpace@Auckland

Description

Cancer cachexia is a syndrome of progressive weight loss. Non-small cell lung cancer patients experience a high incidence of cachexia of 61%. Research into methods to combat cancer cachexia in various tumour sites has recently progressed to the combination of agents.The combination of the anti-cachectic agent Eicosapentaenoic acid (EPA) and the cyclo-oxygenase-2 (COX-2) inhibitor celecoxib has been tested in a small study with some benefit. The use of progressive resistance training (PRT) fol...

Read more

Format

Research paper

Research format

Journal article

Date created

2011

Creator

Rogers, Elaine / MacLeod, Roderick / Stewart, Joanna / Bird, SP / Keogh, JW

URL

http://hdl.handle.net/2292/16335

Related subjects

Adult / Amino Acids, Essential / Cachexia / Carcinoma, Non-Small-Cell Lung / Combined Modality Therapy / Cyclooxygenase 2 Inhibitors / Dietary Supplements / Eicosapentaenoic Acid / Feasibility Studies / Female / Humans / Leucine / Lung Neoplasms / Male / Middle Aged / New Zealand / Patient Satisfaction / Prospective Studies / Pyrazoles / Resistance Training / Sulfonamides

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from The University of Auckland Library before using it.

More Information

The University of Auckland Library has this to say about the rights status of this item:

Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.sherpa.ac.uk/romeo/issn/1471-2407/

You can learn more about the rights status of this item at:

• https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
• http://purl.org/eprint/accessRights/RestrictedAccess

What can I do with this item?

You must always check with The University of Auckland Library to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.